BiomX Adjourns Special Shareholder Meeting for Lack of Quorum

BiomX ( (PHGE) ) has issued an announcement.

On February 25, 2026, BiomX convened a special meeting of stockholders but was forced to adjourn without conducting any business because a quorum was not present. The delay underscores the company’s reliance on broad shareholder participation to approve key proxy proposals and keep its corporate actions on track.

The special meeting is scheduled to reconvene virtually on March 11, 2026, at 8:00 a.m. Eastern Time, with the record date for voting eligibility remaining February 3, 2026. All proposals up for vote are unchanged, signaling that management is focused on securing the necessary votes rather than altering its agenda.

The most recent analyst rating on (PHGE) stock is a Sell with a $4.00 price target. To see the full list of analyst forecasts on BiomX stock, see the PHGE Stock Forecast page.

Spark’s Take on PHGE Stock

According to Spark, TipRanks’ AI Analyst, PHGE is a Neutral.

The score is primarily held down by weak financial performance (no revenue, persistent cash burn, and negative equity) and significant negative corporate developments (trial discontinuation and subsidiary insolvency). Technical indicators are neutral-to-slightly positive and provide limited support, while valuation metrics are constrained by negative earnings; earnings-call updates show clinical/regulatory progress but underscore near-term funding and execution risks.

To see Spark’s full report on PHGE stock, click here.

More about BiomX

BiomX is a biotechnology company focused on developing microbiome-based therapeutics. The company targets diseases driven by dysbiosis of the gut microbiome, aiming to translate advanced microbiological research into clinical-stage treatments for unmet medical needs.

Average Trading Volume: 1,064,614

Technical Sentiment Signal: Sell

Current Market Cap: $6.96M

Find detailed analytics on PHGE stock on TipRanks’ Stock Analysis page.